Entrectinib
About
Therapy type: Targeted therapy
Therapy strategy: ALK inhibition, ROS1 inhibition, NTRK inhibition
Mappings
NCI Thesaurus: Entrectinib (ncit:C114984)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Entrectinib | |
| Sensitivity (+) | v::NTRK1 | Any solid tumor | Entrectinib | |
| Sensitivity (+) | v::NTRK2 | Any solid tumor | Entrectinib | |
| Sensitivity (+) | v::NTRK3 | Any solid tumor | Entrectinib | |
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Entrectinib | |
| Sensitivity (+) | v::NTRK1 | Any solid tumor | Entrectinib | |
| Sensitivity (+) | v::NTRK2 | Any solid tumor | Entrectinib | |
| Sensitivity (+) | v::NTRK3 | Any solid tumor | Entrectinib | |
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Entrectinib | |
| Sensitivity (+) | v::NTRK1 | Any solid tumor | Entrectinib | |
| Sensitivity (+) | v::NTRK2 | Any solid tumor | Entrectinib | |
| Sensitivity (+) | v::NTRK3 | Any solid tumor | Entrectinib |